IMA
IMA
The Icelandic Medicines Agency is the national authority responsible for regulation and surveillance of the development, manufacturing and sale of pharmaceuticals and other medicinal products
84
Employees
At the end of 2022
387.000
Inhabitants in Iceland
At the end of 2022
The IMA is responsible for authorising and licensing medicinal products in the Icelandic market, monitor adverse reactions from medicinal products, authorize clinical trials, decide which medicines are eligible for reimbursement, monitor medical devices available in Iceland and supervise adverse incidents involving medical devices, regulatory surveillance of all pharmacies and pharmacy subsidiaries in Iceland.
2.882
Marketed medicines at the end of 2022
404
Number of MAs issued in 2022
99